Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank100
3Y CAGR+169.5%
5Y CAGR+18.4%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+169.5%/yr
Annual compound
5Y CAGR
+18.4%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.52 | +174.9% |
| 2023 | 0.19 | +396.3% |
| 2022 | 0.04 | +43.4% |
| 2021 | 0.03 | -12.2% |
| 2020 | 0.03 | -86.4% |
| 2019 | 0.22 | - |
| 2018 | 0.00 | - |